Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA ...

For communities worried about PFAS contamination, waiting for test results can mean days of uncertainty. A University of ...

Scientists have created a silicon chip that can write dozens of DNA sequences simultaneously using electricity and ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

Scientists have harnessed artificial-intelligence models to create synthetic CRISPR proteins that edit the genome more ...

Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

Some people from Oceania harbor thousands of genetic variants inherited from the Denisovans ‪—‬ a mysterious group of extinct humans ‪—‬ that are still active in their immune systems today, a new ...